Search bioRxiv⌕ Search

Biology subjects

Ju, C.-W.

Publications and source records attributed to Ju, C.-W..

2 recordsLinked to original sources

ChemXTree: A Tree-enhanced Classification Approach to Small-molecule Drug Discovery

The rapid advancement of machine learning, particularly deep learning, has propelled significant strides in drug discovery, offering novel methodologies for molecular property prediction. However, despite these advancements, existing approaches often face challenges in effectively extracting and selecting relevant features from molecular data, which is crucial for accurate predictions. Our work introduces ChemXTree, a novel graph-based model that integrates tree-based algorithms to address these challenges. By incorporating a Gate Modulation Feature Unit (GMFU) for refined feature selection and a differentiable decision tree in the output layer. Extensive evaluations on benchmark datasets, including MoleculeNet and eight additional drug databases, have demonstrated ChemXTrees superior performance, particularly in feature optimization. Permutation experiments and ablation studies further validate the effectiveness of GMFU, positioning ChemXTree as a significant advancement in molecular informatics, capable of rivaling state-of-the-art models.

bioinformatics↗

m6A mRNA Methylation in Brown Adipose Tissue Regulates Systemic Insulin Sensitivity via an Inter-Organ Prostaglandin Signaling Axis

Brown adipose tissue (BAT) has the capacity to regulate systemic metabolism through the secretion of signaling lipids. N6-methyladenosine (m6A) is the most prevalent and abundant post-transcriptional mRNA modification and has been reported to regulate BAT adipogenesis and energy expenditure. In this study, we demonstrate that the absence of m6A methyltransferase-like 14 (METTL14), modifies the BAT secretome to initiate inter-organ communication to improve systemic insulin sensitivity. Importantly, these phenotypes are independent of UCP1-mediated energy expenditure and thermogenesis. Using lipidomics, we identified prostaglandin E2 (PGE2) and prostaglandin F2a (PGF2a) as M14KO-BAT-secreted insulin sensitizers. Notably, circulatory PGE2 and PGF2a levels are inversely correlated with insulin sensitivity in humans. Furthermore, in vivo administration of PGE2 and PGF2a in high-fat diet-induced insulin-resistant obese mice recapitulates the phenotypes of METTL14 deficient animals. PGE2 or PGF2a improves insulin signaling by suppressing the expression of specific AKT phosphatases. Mechanistically, METTL14-mediated m6A installation promotes decay of transcripts encoding prostaglandin synthases and their regulators in human and mouse brown adipocytes in a YTHDF2/3-dependent manner. Taken together, these findings reveal a novel biological mechanism through which m6A-dependent regulation of BAT secretome regulates systemic insulin sensitivity in mice and humans. HighlightsO_LIMettl14KO-BAT improves systemic insulin sensitivity via inter-organ communication; C_LIO_LIPGE2 and PGF2a are BAT-secreted insulin sensitizers and browning inducers; C_LIO_LIPGE2 and PGF2a sensitize insulin responses through PGE2-EP-pAKT and PGF2a-FP-AKT axis; C_LIO_LIMETTL14-mediated m6A installation selectively destabilizes prostaglandin synthases and their regulator transcripts; C_LIO_LITargeting METTL14 in BAT has therapeutic potential to enhance systemic insulin sensitivity C_LI O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=139 SRC="FIGDIR/small/542169v1_ufig1.gif" ALT="Figure 1"> View larger version (40K): org.highwire.dtl.DTLVardef@16b3393org.highwire.dtl.DTLVardef@1072ae3org.highwire.dtl.DTLVardef@190a6d7org.highwire.dtl.DTLVardef@1b98bce_HPS_FORMAT_FIGEXP M_FIG C_FIG

cell biology↗